FDA Approvals in Oncology: January-March 2026
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
Colorectal cancer cases are becoming more common in younger adults, but there are now more options for screening beyond...
What does a naked mole rat, a nuclear exporter that “moonlights” as a chromatin regulator, and the combined power...
Cancer Today's winter 2025-2026 issue covers delaying stem cell transplants in multiple myeloma, new treatments for brain metastases, and...
The countdown to the new year is nearly upon us, but no need to count down to the last...
In November, the AACR’s journal editors highlighted studies on sucralose limiting immunotherapy, benefits of caloric restriction, and more.
New research is redefining the role of surgery, revealing approaches to help cancer patients preserve their organs, function, and...
For August 2025, the editors of AACR's journals highlighted studies on liquid biopsy for brain cancer, new treatment strategies...
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...
Cancer screenings are key to saving lives. Take colonoscopies, for example, which are estimated to reduce colorectal cancer risk...